These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35283460)

  • 1. Emerging treatment for congenital adrenal hyperplasia.
    White PC
    Curr Opin Endocrinol Diabetes Obes; 2022 Jun; 29(3):271-276. PubMed ID: 35283460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
    Ng SM; Stepien KM; Krishan A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
    Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia.
    Prete A; Auchus RJ; Ross RJ
    Eur J Endocrinol; 2021 Nov; 186(1):R1-R14. PubMed ID: 34735372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital adrenal hyperplasia: New biomarkers and adult treatments.
    Dreves B; Reznik Y; Tabarin A
    Ann Endocrinol (Paris); 2023 Aug; 84(4):472-480. PubMed ID: 36842612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Novel Treatment Strategies in Children with Congenital Adrenal Hyperplasia.
    Nordenström A; Falhammar H; Lajic S
    Horm Res Paediatr; 2023; 96(6):560-572. PubMed ID: 35086098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.
    El-Maouche D; Merke DP; Vogiatzi MG; Chang AY; Turcu AF; Joyal EG; Lin VH; Weintraub L; Plaunt MR; Mohideen P; Auchus RJ
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2771-8. PubMed ID: 32589738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel treatment strategies in congenital adrenal hyperplasia.
    Turcu AF; Auchus RJ
    Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):225-32. PubMed ID: 27032061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management challenges and therapeutic advances in congenital adrenal hyperplasia.
    Mallappa A; Merke DP
    Nat Rev Endocrinol; 2022 Jun; 18(6):337-352. PubMed ID: 35411073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia.
    Ross RJ; Rostami-Hodjegan A
    Horm Res; 2005; 64 Suppl 2():67-70. PubMed ID: 16286775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
    Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency.
    Webb EA; Krone N
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):449-68. PubMed ID: 26051302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
    Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country.
    Utari A; Faradz SMH; Ediati A; Rinne T; Ariani MD; Juniarto AZ; Drop SLS; van Herwaarden AE; Claahsen-van der Grinten HL
    Front Endocrinol (Lausanne); 2022; 13():1015973. PubMed ID: 36589846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of COVID-19 infection in patients with congenital adrenal hyperplasia.
    Javaid R; Sinaii N; Kollender S; Desai J; Moon A; Merke DP
    Front Endocrinol (Lausanne); 2024; 15():1348130. PubMed ID: 38405151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia.
    Liu SC; Suresh M; Jaber M; Mercado Munoz Y; Sarafoglou K
    Front Endocrinol (Lausanne); 2023; 14():1101843. PubMed ID: 36936152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term morbidity in congenital adrenal hyperplasia].
    Tschaidse L; Quitter F; Hübner A; Reisch N
    Internist (Berl); 2022 Jan; 63(1):43-50. PubMed ID: 34978615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal steroidogenesis and congenital adrenal hyperplasia.
    Turcu AF; Auchus RJ
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):275-96. PubMed ID: 26038201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.